STAT3 and Peritoneal Fibrosis: Moreover, our previous studies demonstrated that pharmaceutical and genetic blockade of EGFR leads to dephosphorylation of STAT3 and ERK1/2 and attenuation of renal fibrosis [13]; pharmaceutical inhibition of EGFR/ERK signaling is associated with reduction of peritoneal fibrosis [22].